The GLP-1 Gold Rush: Why Morgan Stanley Just Downgraded Novo Nordisk Amid Fierce Competition

The Weight Loss Revolution: Drugs vs. Surgery – Which Path is Right for You?

Pfizer's Bold Gambit: Unleashing New Weapons in the Global Battle Against Obesity

The Great Rejection: Why Most Americans Are Turning Their Backs on New Weight-Loss Drugs

Beyond Blood Sugar: Ozempic and Zepbound's Unexpected Promise in Psoriasis Treatment

FDA Steps In: Big Pharma's Weight-Loss Claims Under Scrutiny After Oprah Video

The Startling Truth: Half of Weight Loss Drug Users Quit Within a Year

Beyond the Hype: The Hidden Worry Behind Ozempic's Rise

The Unseen Challenge: Why So Many Are Halting Their Semaglutide Weight Loss Journey

Health Horizons: The Hidden Dangers of Your Phone on the Loo & WHO's Bold Stance on Weight-Loss Drugs

The Truth About 'Ozempic Teeth': Unpacking GLP-1 Agonists and Your Oral Health

Global Health Titans Act: FDA Tightens Grip on Safe Weight-Loss Meds as WHO Elevates Them to Essential Status

The WHO's Bold Stance: Backing Weight-Loss Wonders While Championing Affordable Access

A New Era in Health: WHO Adds Mounjaro and Ozempic to Essential Medicines List

WHO's Landmark Decision: Revolutionary Diabetes and Weight-Loss Drugs Added to Essential Medicines List

The Ozempic Obsession: Which U.S. Cities Are Leading the Search for the Weight-Loss Drug?

The Unbearable Weight of Price Tags: Why Life-Changing Weight Loss Drugs Remain Out of Reach

The Weighty Truth: Are Next-Gen Obesity Drugs Worth Their Premium Price Tag?